These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37070996)

  • 21. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic accuracy of perfusion-weighted phase-resolved functional lung magnetic resonance imaging in patients with chronic pulmonary embolism.
    Duan J; Xie S; Sun H; An J; Li H; Li L; Grimm R; Voskrebenzev A; Vogel-Claussen J
    Front Med (Lausanne); 2023; 10():1256925. PubMed ID: 37822465
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Repeatability of dynamic 3D phase-resolved functional lung (PREFUL) ventilation MR Imaging in patients with chronic obstructive pulmonary disease and healthy volunteers.
    Klimeš F; Voskrebenzev A; Gutberlet M; Obert AJ; Pöhler GH; Grimm R; Behrendt L; Crisosto C; Glandorf J; Moher Alsady T; Wacker F; Vogel-Claussen J
    J Magn Reson Imaging; 2021 Aug; 54(2):618-629. PubMed ID: 33565215
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lung perfusion scintigraphy to detect chronic lung allograft dysfunction after living-donor lobar lung transplantation.
    Yamamoto H; Sugimoto S; Kurosaki T; Miyoshi K; Otani S; Okazaki M; Yamane M; Oto T; Toyooka S
    Sci Rep; 2020 Jun; 10(1):10595. PubMed ID: 32601414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Functional and computed tomographic evolution and survival of restrictive allograft syndrome after lung transplantation.
    Verleden SE; de Jong PA; Ruttens D; Vandermeulen E; van Raemdonck DE; Verschakelen J; Vanaudenaerde BM; Verleden GM; Vos R
    J Heart Lung Transplant; 2014 Mar; 33(3):270-7. PubMed ID: 24461432
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of intravenously injected gadolinium-based contrast agents on functional lung parameters derived by PREFUL MRI.
    Glandorf J; Klimeš F; Voskrebenzev A; Gutberlet M; Wacker F; Vogel-Claussen J
    Magn Reson Med; 2020 Mar; 83(3):1045-1054. PubMed ID: 31517406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sequence comparison of spoiled gradient echo and balanced steady-state free precession for pulmonary free-breathing proton MRI in patients and healthy volunteers: Correspondence, repeatability, and validation with dynamic contrast-enhanced MRI.
    Hahn JJ; Voskrebenzev A; Behrendt L; Klimeš F; Pöhler GH; Wacker F; Vogel-Claussen J
    NMR Biomed; 2024 Nov; 37(11):e5209. PubMed ID: 38994704
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in serum KL-6 levels are associated with the development of chronic lung allograft dysfunction in lung transplant recipients.
    Bessa V; Bonella F; Ohshimo S; Weinreich G; Kleibrink B; Costabel U; Aigner C; Kamler M; Taube C; Sommerwerck U
    Transpl Immunol; 2019 Feb; 52():40-44. PubMed ID: 30391371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anti-Thymocyte Globulin as a Therapy for Chronic Lung Allograft Dysfunction: A Single-Center Experience.
    Dunn CT; Brandon W; Jacob A; Zhang S; Gao A; Torres F; Lawrence A; Timofte I; Bollineni S; Mohanka M; Wait M; Peltz M; Heid C; Huffman L; Ring S; Murala J; Keshavamurthy S; Weston AJ; Kaza V
    Clin Transplant; 2024 Oct; 38(10):e15461. PubMed ID: 39365102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relative Lung Perfusion on Ventilation-Perfusion Scans After Double Lung Transplant.
    Li DJ; Abele J; Sunner P; Varughese RA; Hirji AS; Weinkauf JG; Nagendran J; Weatherald JC; Lien DC; Halloran KM
    Transplantation; 2023 Oct; 107(10):2262-2270. PubMed ID: 37291709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extreme elevations of donor-derived cell-free DNA increases the risk of chronic lung allograft dysfunction and death, even without clinical manifestations of disease.
    Keller MB; Newman D; Alnababteh M; Ponor L; Shah P; Mathew J; Kong H; Andargie T; Park W; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Sep; 43(9):1374-1382. PubMed ID: 38705500
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Association of Post-Lung Transplant Pulmonary Embolism With the Development of Chronic Lung Allograft Dysfunction.
    Magin JC; Xu C; Peskoe S; Dorry M; Frankel CW; Dahhan T; Snyder LD
    Transplant Direct; 2024 Feb; 10(2):e1572. PubMed ID: 38264297
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence and impact of chronic lung allograft dysfunction after lung transplantation - single-center 14-year experience.
    Nykänen A; Raivio P; Peräkylä L; Stark C; Huuskonen A; Lemström K; Halme M; Hämmäinen P
    Scand Cardiovasc J; 2020 Jun; 54(3):192-199. PubMed ID: 32148103
    [No Abstract]   [Full Text] [Related]  

  • 35. Impact of forced vital capacity loss on survival after the onset of chronic lung allograft dysfunction.
    Todd JL; Jain R; Pavlisko EN; Finlen Copeland CA; Reynolds JM; Snyder LD; Palmer SM
    Am J Respir Crit Care Med; 2014 Jan; 189(2):159-66. PubMed ID: 24325429
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Validation of a post-transplant chronic lung allograft dysfunction classification system.
    Van Herck A; Verleden SE; Sacreas A; Heigl T; Vanaudenaerde BM; Dupont LJ; Yserbyt J; Verbeken EK; Neyrinck AP; Van Raemdonck D; Verleden GM; Vos R
    J Heart Lung Transplant; 2019 Feb; 38(2):166-173. PubMed ID: 30391199
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Impact of Inadequate ("AX") Transbronchial Biopsies on Post-lung Transplant CLAD or Death.
    Levy L; Huszti E; Pal P; Tikkanen J; Ghany R; Keshavjee S; Martinu T; Singer LG
    Transplantation; 2021 Feb; 105(2):390-395. PubMed ID: 32150039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of CT-SCAN score and volume measures to early identify restrictive allograft syndrome in single lung transplant recipients.
    Philippot Q; Debray MP; Bun R; Frija-Masson J; Bunel V; Morer L; Roux A; Picard C; Jebrak G; Dauriat G; Castier Y; Cazes A; Mal H; Taupin JL; Couffignal C; Brugière O
    J Heart Lung Transplant; 2020 Feb; 39(2):125-133. PubMed ID: 31836403
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phenotyping Chronic Lung Allograft Dysfunction Using Body Plethysmography and Computed Tomography.
    Suhling H; Dettmer S; Greer M; Fuehner T; Avsar M; Haverich A; Welte T; Gottlieb J
    Am J Transplant; 2016 Nov; 16(11):3163-3170. PubMed ID: 27203799
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Restrictive allograft syndrome (RAS): a novel form of chronic lung allograft dysfunction.
    Sato M; Waddell TK; Wagnetz U; Roberts HC; Hwang DM; Haroon A; Wagnetz D; Chaparro C; Singer LG; Hutcheon MA; Keshavjee S
    J Heart Lung Transplant; 2011 Jul; 30(7):735-42. PubMed ID: 21419659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.